# Apremilast Therapy for Acute Gouty Arthritis

> **NCT00997581** · PHASE2 · WITHDRAWN · sponsor: **Dartmouth-Hitchcock Medical Center**

## Conditions studied

- Acute Gout

## Interventions

- **DRUG:** apremilast
- **DRUG:** indomethacin SR

## Key facts

- **NCT ID:** NCT00997581
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-04
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Colaborator withdrew support.
- **Last updated:** 2018-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997581, "Apremilast Therapy for Acute Gouty Arthritis". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00997581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*